| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |